1
|
Hosnedlova B, Werle J, Cepova J, Narayanan VHB, Vyslouzilova L, Fernandez C, Parikesit AA, Kepinska M, Klapkova E, Kotaska K, Stepankova O, Bjorklund G, Prusa R, Kizek R. Electrochemical Sensors and Biosensors for Identification of Viruses: A Critical Review. Crit Rev Anal Chem 2024:1-30. [PMID: 38753964 DOI: 10.1080/10408347.2024.2343853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/18/2024]
Abstract
Due to their life cycle, viruses can disrupt the metabolism of their hosts, causing diseases. If we want to disrupt their life cycle, it is necessary to identify their presence. For this purpose, it is possible to use several molecular-biological and bioanalytical methods. The reference selection was performed based on electronic databases (2020-2023). This review focused on electrochemical methods with high sensitivity and selectivity (53% voltammetry/amperometry, 33% impedance, and 12% other methods) which showed their great potential for detecting various viruses. Moreover, the aforementioned electrochemical methods have considerable potential to be applicable for care-point use as they are portable due to their miniaturizability and fast speed analysis (minutes to hours), and are relatively easy to interpret. A total of 2011 articles were found, of which 86 original papers were subsequently evaluated (the majority of which are focused on human pathogens, whereas articles dealing with plant pathogens are in the minority). Thirty-two species of viruses were included in the evaluation. It was found that most of the examined research studies (77%) used nanotechnological modifications. Other ones performed immunological (52%) or genetic analyses (43%) for virus detection. 5% of the reports used peptides to increase the method's sensitivity. When evaluable, 65% of the research studies had LOD values in the order of ng or nM. The vast majority (79%) of the studies represent proof of concept and possibilities with low application potential and a high need of further research experimental work.
Collapse
Affiliation(s)
- Bozena Hosnedlova
- BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
| | - Julia Werle
- Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
| | - Jana Cepova
- Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
| | - Vedha Hari B Narayanan
- Pharmaceutical Technology Lab, School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, India
| | - Lenka Vyslouzilova
- Czech Institute of Informatics, Robotics and Cybernetics, Department of Biomedical Engineering & Assistive Technologies, Czech Technical University in Prague, Prague, Czech Republic
| | - Carlos Fernandez
- School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, United Kingdom
| | - Arli Aditya Parikesit
- Department of Bioinformatics, School of Life Sciences, Indonesia International Institute for Life Sciences, Jakarta, Timur, Indonesia
| | - Marta Kepinska
- Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland
| | - Eva Klapkova
- Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
| | - Karel Kotaska
- Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
| | - Olga Stepankova
- Czech Institute of Informatics, Robotics and Cybernetics, Department of Biomedical Engineering & Assistive Technologies, Czech Technical University in Prague, Prague, Czech Republic
| | - Geir Bjorklund
- Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway
| | - Richard Prusa
- Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
| | - Rene Kizek
- Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
| |
Collapse
|
2
|
Gholami A, Mousavi SM, Masoumzadeh R, Binazadeh M, Bagheri Lankarani K, Omidifar N, Arjmand O, Chiang WH, Moghadami M, Pynadathu Rumjit N. Advanced Theranostic Strategies for Viral Hepatitis Using Carbon Nanostructures. MICROMACHINES 2023; 14:1185. [PMID: 37374770 DOI: 10.3390/mi14061185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 05/27/2023] [Accepted: 05/29/2023] [Indexed: 06/29/2023]
Abstract
There are several treatment protocols for acute viral hepatitis, and it is critical to recognize acute hepatitis in its earliest stages. Public health measures to control these infections also rely on rapid and accurate diagnosis. The diagnosis of viral hepatitis remains expensive, and there is no adequate public health infrastructure, while the virus is not well-controlled. New methods for screening and detecting viral hepatitis through nanotechnology are being developed. Nanotechnology significantly reduces the cost of screening. In this review, the potential of three-dimensional-nanostructured carbon substances as promising materials due to fewer side effects, and the contribution of these particles to effective tissue transfer in the treatment and diagnosis of hepatitis due to the importance of rapid diagnosis for successful treatment, were extensively investigated. In recent years, three-dimensional carbon nanomaterials such as graphene oxide and nanotubes with special chemical, electrical, and optical properties have been used for the diagnosis and treatment of hepatitis due to their high potential. We expect that the future position of nanoparticles in the rapid diagnosis and treatment of viral hepatitis can be better determined.
Collapse
Affiliation(s)
- Ahmad Gholami
- Biotechnology Research Center, Shiraz University of Medical Science, Shiraz 71439-14693, Iran
- Pharmaceutical Sciences Research Center, Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Shiraz University of Medical Science, Shiraz 71439-14693, Iran
| | - Seyyed Mojtaba Mousavi
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
| | - Reza Masoumzadeh
- Department of Medical, Shiraz University of Medical Sciences, Shiraz 71439-14693, Iran
| | - Mojtaba Binazadeh
- Department of Chemical Engineering, School of Chemical and Petroleum Engineering, Shiraz 71557-13876, Iran
| | - Kamran Bagheri Lankarani
- Health Policy Research Center, Health Institute, Shiraz University of Medical Sciences, Shiraz 71439-14693, Iran
| | - Navid Omidifar
- Biotechnology Research Center, Shiraz University of Medical Science, Shiraz 71439-14693, Iran
- Department of Pathology, Shiraz University of Medical Sciences, Shiraz 71439-14693, Iran
| | - Omid Arjmand
- Department of Chemical Engineering, South Tehran Branch, Islamic Azad University, Tehran 14687-63785, Iran
| | - Wei-Hung Chiang
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
| | - Mohsen Moghadami
- Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz 71439-14693, Iran
| | - Nelson Pynadathu Rumjit
- Nanotechnology and Catalysis Research Centre (NANOCAT), Level 3, Block A, Institute for Advanced Studies (IAS), University of Malaya (UM), Kuala Lumpur 50603, Malaysia
| |
Collapse
|
4
|
Ebrahimi M, Asadi M, Akhavan O. Graphene-based Nanomaterials in Fighting the Most Challenging Viruses and Immunogenic Disorders. ACS Biomater Sci Eng 2021; 8:54-81. [PMID: 34967216 DOI: 10.1021/acsbiomaterials.1c01184] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Viral diseases have long been among the biggest challenges for healthcare systems around the world. The recent Coronavirus Disease 2019 (COVID-19) pandemic is an example of how complicated the situation can get if we are not prepared to combat a viral outbreak in time, which brings up the need for quick and affordable biosensing platforms and vast knowledge of potential antiviral effects and drug/gene delivery opportunities. The same challenges have also existed for nonviral immunogenic disorders. Nanomedicine is considered a novel candidate for effectively overcoming these worldwide challenges. Among the versatile nanomaterials commonly used in biomedical applications, graphene has recently earned much attention thanks to its special and inspiring physicochemical properties, such as its large surface area, efficient thermal/electrical properties, carbon-based chemical purity with controllable biocompatibility, easy functionalization, capability of single-molecule detection, anticancer characteristics, 3D template feature in tissue engineering, and, in particular, antibacterial/antiviral activities. In this Review, the most important and challenging viruses of our era, such as human immunodeficiency virus, Ebola, SARS-CoV-2, norovirus, and hepatitis virus, and immunogenic disorders, such as asthma, Alzheimer's disease, and Parkinson's disease, in which graphene-based nanomaterials can effectively take part in the prevention, detection, treatment, medication, and health effect issues, have been covered and discussed.
Collapse
Affiliation(s)
- Mahsa Ebrahimi
- Department of Physics, Sharif University of Technology, 11155-9161 Tehran, Islamic Republic of Iran
| | - Mohamad Asadi
- Department of Electrical Engineering, Sharif University of Technology, 11155-4363 Tehran, Islamic Republic of Iran
| | - Omid Akhavan
- Department of Physics, Sharif University of Technology, 11155-9161 Tehran, Islamic Republic of Iran
| |
Collapse
|
5
|
Application of carbon nanomaterials in human virus detection. JOURNAL OF SCIENCE: ADVANCED MATERIALS AND DEVICES 2020; 5. [PMCID: PMC7509950 DOI: 10.1016/j.jsamd.2020.09.005] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
Human-pathogenic viruses are still a chief reason for illness and death on the globe, as epitomized by the COVID-19 pandemic instigated by a coronavirus in 2020. Multiple novel sensors have been invented because diseases must be detected and diagnosed as early as possible, and recognition methods have to be carried out with minimal invasivity. Sensors have been particularly developed focusing on miniaturization by the use of nanomaterials for fabricating nanosensors. The nano-sized nature of nanomaterials and their exclusive optical, electronical, magnetical, and mechanical attributes can enhance patient care through the use of sensors with minimal invasivity and extreme sensitivity. Amongst the nanomaterials utilized for fabricating nano-sensors, carbon-based nanomaterials are promising as these sensors respond better to signals in various sensing settings. This review provides an overview of the recent developments in carbon nanomaterial-based biosensors for viral recognition based on the biomarkers that arise from the infection, the nucleic acids from the viruses, and the entire virus. The role of carbon nanomaterials is highlighted by the improvement of sensor and recognition functionality. The Dengue virus, Ebola virus, Hepatits virus, human immunodeficiency virus (HIV), influenza virus, Zika virus and Adenovirus are the virus types reviewed to illustrate the implementation of the techniques. Finally, the drawbacks and advantages of carbon nanomaterial-based biosensors for viral recognition are identified and discussed.
Collapse
|